MOLECULAR IMAGING OF THE NICOTINIC CHOLINERGIC RECEPTOR IN PARKINSON'S DISEASE (PD): IMPLICATION OF FOR UNDERSTANDING THE NEUROBIOLOGY OF COGNITIVE IMPAIRMENT